Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer

Human Pathology

Volumn 44, Issue 10, 2013, Pages 2338-2345

  Shibahara, Yukiko ^a   Miki, Yasuhiro ^a   Sakurada, Chikako ^a   Uchida, Keiko ^a   Hata, Shuko ^a   McNamara, Keely ^a   Yoda, Tomomi ^a   Takagi, Kiyoshi ^a   Nakamura, Yasuhiro ^a   Suzuki, Takashi ^a   Ishida, Takanori ^a   Ohuchi, Noriaki ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Androgen; Breast cancer; Immunohistochemistry; Lymph node; Metastasis; Steroid metabolism

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; STEROID 5ALPHA REDUCTASE 1; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE TYPE 5; UNCLASSIFIED DRUG;

ADULT; AGED; ANDROGEN METABOLISM; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIMARY TUMOR; PROTEIN EXPRESSION;

ANDROGEN; BREAST CANCER; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METASTASIS; STEROID METABOLISM;

17-HYDROXYSTEROID DEHYDROGENASES; 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; ADULT; AGED; AGED, 80 AND OVER; ANDROGENS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL PROLIFERATION; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ANDROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84884415507     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.04.021     Document Type: Article

References (22)

1. J.P. Garay, and B.H. Park Androgen receptor as a targeted therapy for breast cancer Am J Cancer Res 2 2012 434 445
2. T.E. Hickey, J.L. Robinson, J.S. Carroll, and W.D. Tilley Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 26 2012 1252 1267
3. A. Gucalp, and T.A. Traina Triple-negative breast cancer: role of the androgen receptor Cancer J 16 2010 62 65
4. K.M. McNamara, T. Yoda, K. Takagi, Y. Miki, T. Suzuki, and H. Sasano Androgen receptor in triple negative breast cancer J Steroid Biochem Mol Biol 133 2013 66 76
5. S.J. Aitken, J.S. Thomas, S.P. Langdon, D.J. Harrison, and D. Faratian Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases Ann Oncol 21 2009 1254 1261
6. Y. Shibahara, Y. Miki, and T. Ishida Immunohistochenical analysis of aromatase in metastatic lymph nodes of breast cancer Pathol Int 1 2013 20 28
7. A. Cimino-Mathews, J.L. Hicks, and P.B. Illei Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy Hum Pathol 43 2012 1003 1011
8. T. Suzuki, Y. Miki, and Y. Nakamura Sex steroid-producing enzymes in human breast cancer Endocr Relat Cancer 12 2005 701 720
9. T. Suzuki, Y. Miki, and T. Moriya 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production Int J Cancer 120 2007 285 291
10. D.C. Allred, J.M. Harvey, M. Berardo, and G.M. Clark Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 1998 155 168
11. D.N. Díaz-Chico, F. Germán Rodriguez, and A. González Androgens and androgen receptors in breast cancer J Steroid Biochem Mol Biol 105 2007 1 15
12. A.A. Peters, G. Buchanan, and C. Ricciardelli Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer Cancer Res 69 2009 6131 6140
13. K.M. Peters, S.L. Edwards, and S.S. Nair Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events BMC Cancer 12 2012 132
14. J.A. Søreide, O.A. Lea, J.E. Varhaug, A. Skarstein, and S. Kvinnsland Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment Eur J Surg Oncol 18 1992 112 118
15. M. Bryś, M. Wójcik, H. Romanowicz-Makowska, and W.M. Krajewska Androgen receptor status in female breast cancer: RT-PCR and Western blot studies J Cancer Res Clin Oncol 128 2002 85 90
16. P. Vihko, A. Herrala, and P. Harkonen Enzymes as modulators in malignant transformation J Steroid Biochem Mol Biol 93 2005 277 283
17. T. Suzuki, A.D. Darnel, and J.I. Akahira 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions J Clin Endocrinol Metab 86 2001 2250 2257
18. F.G. Wiesner, A. Magener, and P.A. Fasching Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients Breast 18 2009 135 141
19. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 41 2002 154 161
20. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
21. L. Sobin, M. Gospodarowicz, and C. Wittekind TNM Classification of Malignant Tumours 7th ed 2009 Wiley Blackwell Bognor Regis, UK
22. S.J. Schnitt, J.L. Connolly, and F.A. Tavassoli Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria Am J Surg Pathol 16 1992 1133 1143